Physician

Shiv Kumar, MD

According to 2025 Medicare claims, Shiv Kumar, MD (NPI: 1326076555) practices nephrology in the Rockingham County-Strafford County, NH market, with the plurality of this provider's patient population coming from Strafford, NH. This provider's primary affiliated billing organization is SEACOAST KIDNEY & HYPERTENSION SPECIALISTS, P.L.L.C. (NPI: 1780877902; TIN: 260697394) and primary practice location at 03878-4300. Kumar is affiliated with the Aledade 201 National MSSP (ACO ID: A5522), participating under the MSSP model.

Kumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 522 traditional Medicare patients, billed 1,761 HCPCS/CPT codes, and received $227,392 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 797 prescription claims across 187 beneficiaries totaling $65,865 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 42 claims. Open Payments data shows 1 records totaling $77. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $209,792 to $65,865. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	728	2,668	$256,693
2016	668	2,439	$249,151
2017	683	2,451	$260,614
2018	687	2,298	$249,794
2019	660	2,399	$256,701
2020	599	1,970	$254,842
2021	619	2,009	$278,865
2022	602	2,068	$285,613
2023	562	1,951	$246,156
2024	522	1,761	$227,392

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	226	1,348	$209,792
2016	202	1,098	$216,264
2017	205	1,071	$168,773
2018	186	993	$56,473
2019	206	962	$57,458
2020	205	913	$60,019
2021	211	975	$67,648
2022	195	923	$63,690
2023	186	891	$68,646
2024	187	797	$65,865

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	19	$358
2017	N/R	N/R	N/R
2018	N/R	12	$270
2019	N/R	49	$919
2020	N/R	67	$1,600
2021	N/R	50	$1,118
2022	N/R	35	$752
2023	N/R	30	$649
2024	N/R	42	$688

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	97	400	$281
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	94	114	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	215	341	$91
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	158	378	$61
90935	Hemodialysis procedure with physician evaluation	54	135	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	13	570	$10,176
Torsemide	Torsemide	67	4,670	$1,016
Losartan Potassium	Losartan Potassium	80	6,205	$637
Irbesartan	Irbesartan	13	1,170	$545
Furosemide	Furosemide	67	4,508	$497

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	11	$324
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	20	$213
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	11	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$77	CALLIDITAS THERAPEUTICS US INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shiv Kumar, MD?

Tedicare shows public-source Medicare data for Shiv Kumar, MD (NPI 1326076555), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shiv Kumar, MD have ACO affiliation data?

Shiv Kumar, MD is shown with ACO affiliation data for Aledade 201 National MSSP (MSSP, ACO ID A5522).

What billing organization is linked to Shiv Kumar, MD?

Shiv Kumar, MD is linked to SEACOAST KIDNEY & HYPERTENSION SPECIALISTS, P.L.L.C. (billing NPI 1780877902) in the available physician profile data.

Does Shiv Kumar, MD have Open Payments data?

Shiv Kumar, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.